Talphera (TLPH) News
NASDAQ: TLPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
TLPH news summary
We found 2 recent headlines mentioning Talphera (TLPH): 0 in the past week and 2 in the past 30 days, most often from Nasdaq. TLPH is making an outsized move today, up 6.25% at $0.7852, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Talphera, Inc. Reports Third Quarter 2026 Financial Results and Proposes Early Close of NEPHRO CRRT Study Enrollment", was published by Nasdaq on Nov 13, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Talphera headlines
- Talphera, Inc. Reports Third Quarter 2026 Financial Results and Proposes Early Close of NEPHRO CRRT Study EnrollmentTalphera, Inc. announced its financial results for the third quarter of 2026 and provided a business update, including a proposal to close enrollment early for its pivotal NEPHRO CRRT study. The…Nasdaq
- Talphera (TLPH) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq